Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MOH

Deciphering Molina Healthcare Inc's Stock Surge Today

Molina Healthcare Inc stock is trading -11.28% below its average target price of $203.07 after marking a 3.1% during today's afternoon session. Analysts are giving the Mid-Cap Medical Specialities company an average rating of hold and target prices ranging from $153.0 to $330.0 per share.

The stock has an average amount of shares sold short at 5.4%, and a short ratio of 1.05. Since 1.3% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 99.6% of Molina Healthcare Inc's shares being owned by this investor type.

Institutions Invested in Molina Healthcare Inc

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 12% 6,433,639 $1,159,084,425
2025-06-30 Capital World Investors 10% 5,270,484 $949,530,416
2025-06-30 Blackrock Inc. 9% 4,735,179 $853,089,865
2025-06-30 FMR, LLC 5% 2,514,232 $452,964,046
2025-06-30 State Street Corporation 5% 2,459,996 $443,192,888
2025-06-30 Price (T.Rowe) Associates Inc 4% 2,206,422 $397,508,995
2025-06-30 Capital Research Global Investors 4% 2,166,093 $390,243,322
2025-06-30 Wellington Management Group, LLP 4% 2,077,084 $374,207,461
2025-06-30 Capital International Investors 3% 1,626,068 $292,952,416
2025-06-30 Invesco Ltd. 3% 1,601,574 $288,539,577

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Molina Healthcare Inc.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS